Phenotypical and functional alterations during the expansion phase of invariant Vα14 natural killer T (Vα14i NKT) cells in mice primed with α-galactosylceramide

Por Ikarashi, Yoshinori, Iizuka, Akira, Koshidaka, Yumie, Heike, Yuji, Takaue, Yoichi, Yoshida, Mitsuzi, Kronenberg, Mitchell, Wakasugi, Hiro
Publicado em 2005

Pulmonary adenocarcinoma possibly developed from the cut-end of small-sized adenocarcinoma in the lung periphery as recurrence 13 years after its wedge resection

Por Hanaoka, Takaomi, Kurai, Makoto, Okada, Mitsuyo, Ishizone, Satoshi, Karasawa, Fumitoshi, Iizuka, Akira, Ikeyama, Meguru, Nakayama, Jun
Publicado no Surg Case Rep (2018)

Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia

Por Torashima, Takashi, Koyama, Chiho, Iizuka, Akira, Mitsumura, Kazuhiro, Takayama, Kiyohiko, Yanagi, Shigeru, Oue, Miho, Yamaguchi, Haruyasu, Hirai, Hirokazu
Publicado em 2008

Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-γ and IL-4

Por Iizuka, Akira, Ikarashi, Yoshinori, Yoshida, Mitsuzi, Heike, Yuji, Takeda, Kazuyoshi, Quinn, Gary, Wakasugi, Hiro, Kitagawa, Masanobu, Takaue, Yoichi
Publicado em 2008

Immunologically augmented skin flap as a novel dendritic cell vaccine against head and neck cancer in a rat model

Por Inoue, Keita, Saegusa, Noriko, Omiya, Maho, Ashizawa, Tadashi, Miyata, Haruo, Komiyama, Masaru, Iizuka, Akira, Kume, Akiko, Sugino, Takashi, Yamaguchi, Ken, Kiyohara, Yoshio, Nakagawa, Masahiro, Akiyama, Yasuto
Publicado no Cancer Sci (2015)

Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line

Por MIYATA*, HARUO, ASHIZAWA*, TADASHI, IIZUKA, AKIRA, KONDOU, RYOTA, NONOMURA, CHIZU, SUGINO, TAKASHI, URAKAMI, KENICHI, ASAI, AKIRA, HAYASHI, NAKAMASA, MITSUYA, KOICHI, NAKASU, YOKO, YAMAGUCHI, KEN, AKIYAMA, YASUTO
Publicado no Cancer Genomics Proteomics (2016)

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

Por Akiyama Yasuto, Oshita Chie, Kume Akiko, Iizuka Akira, Miyata Haruo, Komiyama Masaru, Ashizawa Tadashi, Yagoto Mika, Abe Yoshiaki, Mitsuya Koichi, Watanabe Reiko, Sugino Takashi, Yamaguchi Ken, Nakasu Yoko
Publicado em 2012-12-01

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

Por Akiyama, Yasuto, Oshita, Chie, Kume, Akiko, Iizuka, Akira, Miyata, Haruo, Komiyama, Masaru, Ashizawa, Tadashi, Yagoto, Mika, Abe, Yoshiaki, Mitsuya, Koichi, Watanabe, Reiko, Sugino, Takashi, Yamaguchi, Ken, Nakasu, Yoko
Publicado em 2012

Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial

Por OSHITA, CHIE, TAKIKAWA, MASAKO, KUME, AKIKO, MIYATA, HARUO, ASHIZAWA, TADASHI, IIZUKA, AKIRA, KIYOHARA, YOSHIO, YOSHIKAWA, SHUSUKE, TANOSAKI, RYUJI, YAMAZAKI, NAOYA, YAMAMOTO, AKIFUMI, TAKESAKO, KAZUTOH, YAMAGUCHI, KEN, AKIYAMA, YASUTO
Publicado em 2012